2348 — Dawnrays Pharmaceutical (Holdings) Share News
0.000.00%
Last trade - 00:00- HK$1.57bn
- -HK$170.23m
- CNY1.23bn
Brief: Dawnrays Pharmaceutical Says Cetirizine Hydrochloride Tablets 10Mg Granted Approval By NMPA
Brief: Dawnrays Pharmaceutical Enters Into MAH Assignment Agreement With Nanjing Haina
Brief: Dawnrays Pharmaceutical Says Anti-Infective Drug Of Suzhou Dawnrays Obtained Approval
HK Exchange says 21 firms buy back shares
HK Exchange says 20 firms buy back shares
HK Exchange says 22 firms buy back shares
HK Exchange says 23 firms buy back shares
Brief: Dawnrays Pharmaceutical Holdings Posts FY Profit Attributable RMB304 Mln
Brief: Dawnrays Pharmaceutical Holdings Announces Framework Agreement For Acquisition Of Top Field
Brief: Dawnrays Pharmaceutical Says 16 Mln Share Options Granted To Subscribe For A Total Of 16 Mln New Ordinary Shares
Brief: Dawnrays Pharmaceutical Holdings Posts H1 Profit Attributable RMB166.2 Mln
Brief: Dawnrays Pharmaceutical Holdings Recommends Special Dividend
Brief: Dawnrays Pharmaceutical Says FY Profit For Year RMB293.0 Mln
Brief: Dawnrays Pharmaceutical (Holdings) Says Li Tung Ming Resigns As Executive Director
Brief: Dawnrays Pharmaceutical Appoints Chen Shaojun As Executive Director
Brief: Dawnrays Pharmaceutical (Holdings) Suzhou Dawnrays To Receive RMB351.2 Mln
Brief: Dawnrays Pharmaceutical says HY revenue was up 17.4 percent
Brief: Dawnrays Pharmaceutical notified that a director was charged for conspiracy to defraud
Brief: Dawnrays pharmaceutical says enters into JV agreement with Zhongshan KF